Matches in SemOpenAlex for { <https://semopenalex.org/work/W2317736763> ?p ?o ?g. }
Showing items 1 to 86 of
86
with 100 items per page.
- W2317736763 abstract "Introduction and Objectives Chronic propranolol does not improve airway hyper-responsiveness (AHR) in persistent asthmatics taking medium dose inhaled corticosteroid (ICS), 440µg/day1. We wished to assess for any putative corticosteroid-sparing effect of propranolol added to low dose ICS versus higher dose ICS, on histamine AHR. Methods We conducted a randomised double-blind placebo-controlled crossover trial in mild-moderate persistent asthmatics. Patients were run-in for 2 weeks on hydrofluoroalkane-beclometasone dipropionate (HFA-BDP) 100µg/day. Patients were then randomised to either: propranolol 80mg/day plus HFA-BDP 100µg/day; or placebo plus HFA-BDP 400µg/day, each for 4 weeks. Propranolol was up-titrated to 80mg/day for the second 2 weeks of treatment. Patients received tiotropium 18µg/day during run-in and both treatments, which was subsequently discontinued 5 days prior to histamine challenge (primary outcome). Results 16 patients completed, mean: age 38yr; FEV1 86.4%; Histamine PC20 1.39mg/ml; ICS 406µg/day. Histamine PC20 remained unchanged adding propranolol to HFA-BDP100 compared to baseline (HFA-BDP100): 0.17 doubling dilution (dd) difference (95%CI -0.58–0.92), but there was a significant improvement with HFA-BDP400 compared to both baseline 1.05dd (95%CI 0.43–1.66), P = 0.02; and propranolol 0.88dd (95%CI 0.45–1.30), P = 0.006 (Figure 1a). Significant improvements from baseline were observed with HFA-BDP400 for exhaled nitric oxide, blood eosinophils (Figure 1b) and Asthma Quality of Life Questionnaire (AQLQ) symptom score (Figure 1c), but not with propranolol. Salbutamol recovery time post-challenge was partially blunted by propranolol (median prolongation 5min compared to both baseline and HFA-BDP400, P = 0.002). Domiciliary evening FEV1 also fell with propranolol (mean reduction from baseline 0.22L [95%CI 0.10–0.34L], P = 0.012) while Asthma Control Questionnaire (ACQ) showed no significant changes with either treatment compared to baseline. Conclusions In mild-moderate persistent asthmatics, propranolol produced no additive effects on top of low dose ICS, while further significant improvements in AHR and inflammation were seen with a higher dose of ICS. Propranolol attenuated salbutamol recovery and reduced evening FEV1, but not ACQ or AQLQ. References Short PM, Williamson PA, Anderson WJ, Lipworth BJ. Randomised placebo- controlled trial to evaluate chronic dosing effects of propranolol in asthma. Am J Respir Crit Care Med 2013;187:1308–1314." @default.
- W2317736763 created "2016-06-24" @default.
- W2317736763 creator A5020658910 @default.
- W2317736763 creator A5060793550 @default.
- W2317736763 creator A5071646699 @default.
- W2317736763 creator A5085399720 @default.
- W2317736763 creator A5088424941 @default.
- W2317736763 date "2013-11-14" @default.
- W2317736763 modified "2023-09-24" @default.
- W2317736763 title "P162 Effect of adding propranolol or increased inhaled corticosteroid dose in persistent asthma" @default.
- W2317736763 cites W2101988937 @default.
- W2317736763 doi "https://doi.org/10.1136/thoraxjnl-2013-204457.313" @default.
- W2317736763 hasPublicationYear "2013" @default.
- W2317736763 type Work @default.
- W2317736763 sameAs 2317736763 @default.
- W2317736763 citedByCount "1" @default.
- W2317736763 countsByYear W23177367632014 @default.
- W2317736763 crossrefType "journal-article" @default.
- W2317736763 hasAuthorship W2317736763A5020658910 @default.
- W2317736763 hasAuthorship W2317736763A5060793550 @default.
- W2317736763 hasAuthorship W2317736763A5071646699 @default.
- W2317736763 hasAuthorship W2317736763A5085399720 @default.
- W2317736763 hasAuthorship W2317736763A5088424941 @default.
- W2317736763 hasBestOaLocation W23177367631 @default.
- W2317736763 hasConcept C126322002 @default.
- W2317736763 hasConcept C142724271 @default.
- W2317736763 hasConcept C204787440 @default.
- W2317736763 hasConcept C27081682 @default.
- W2317736763 hasConcept C2776042228 @default.
- W2317736763 hasConcept C2776178081 @default.
- W2317736763 hasConcept C2776804153 @default.
- W2317736763 hasConcept C2776954882 @default.
- W2317736763 hasConcept C2777714996 @default.
- W2317736763 hasConcept C2777992530 @default.
- W2317736763 hasConcept C2778151854 @default.
- W2317736763 hasConcept C2780769369 @default.
- W2317736763 hasConcept C2781142857 @default.
- W2317736763 hasConcept C42219234 @default.
- W2317736763 hasConcept C71924100 @default.
- W2317736763 hasConcept C87813604 @default.
- W2317736763 hasConcept C90924648 @default.
- W2317736763 hasConceptScore W2317736763C126322002 @default.
- W2317736763 hasConceptScore W2317736763C142724271 @default.
- W2317736763 hasConceptScore W2317736763C204787440 @default.
- W2317736763 hasConceptScore W2317736763C27081682 @default.
- W2317736763 hasConceptScore W2317736763C2776042228 @default.
- W2317736763 hasConceptScore W2317736763C2776178081 @default.
- W2317736763 hasConceptScore W2317736763C2776804153 @default.
- W2317736763 hasConceptScore W2317736763C2776954882 @default.
- W2317736763 hasConceptScore W2317736763C2777714996 @default.
- W2317736763 hasConceptScore W2317736763C2777992530 @default.
- W2317736763 hasConceptScore W2317736763C2778151854 @default.
- W2317736763 hasConceptScore W2317736763C2780769369 @default.
- W2317736763 hasConceptScore W2317736763C2781142857 @default.
- W2317736763 hasConceptScore W2317736763C42219234 @default.
- W2317736763 hasConceptScore W2317736763C71924100 @default.
- W2317736763 hasConceptScore W2317736763C87813604 @default.
- W2317736763 hasConceptScore W2317736763C90924648 @default.
- W2317736763 hasLocation W23177367631 @default.
- W2317736763 hasLocation W23177367632 @default.
- W2317736763 hasOpenAccess W2317736763 @default.
- W2317736763 hasPrimaryLocation W23177367631 @default.
- W2317736763 hasRelatedWork W1890804524 @default.
- W2317736763 hasRelatedWork W1987062528 @default.
- W2317736763 hasRelatedWork W1998329899 @default.
- W2317736763 hasRelatedWork W2070455290 @default.
- W2317736763 hasRelatedWork W2090482216 @default.
- W2317736763 hasRelatedWork W2264541031 @default.
- W2317736763 hasRelatedWork W2267482260 @default.
- W2317736763 hasRelatedWork W2270324480 @default.
- W2317736763 hasRelatedWork W2334294997 @default.
- W2317736763 hasRelatedWork W2360444783 @default.
- W2317736763 hasRelatedWork W2368962946 @default.
- W2317736763 hasRelatedWork W2371533833 @default.
- W2317736763 hasRelatedWork W2373063133 @default.
- W2317736763 hasRelatedWork W2375183476 @default.
- W2317736763 hasRelatedWork W2387665018 @default.
- W2317736763 hasRelatedWork W2399883159 @default.
- W2317736763 hasRelatedWork W2411493719 @default.
- W2317736763 hasRelatedWork W2416684112 @default.
- W2317736763 hasRelatedWork W2463089876 @default.
- W2317736763 hasRelatedWork W2949271607 @default.
- W2317736763 isParatext "false" @default.
- W2317736763 isRetracted "false" @default.
- W2317736763 magId "2317736763" @default.
- W2317736763 workType "article" @default.